<DOC>
	<DOC>NCT00770003</DOC>
	<brief_summary>The primary purpose is to investigate tolerability/safety of repeated weekly doses of AZD8848 administered intranasally to seasonal allergic rhinitis patients.</brief_summary>
	<brief_title>Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis, Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Patients with a history of birch and/ or timothy grass pollen induced seasonal allergic rhinitis for at least the previous 2 years (verified by a positive skin prick test) Patients with need of treatment for their nasal symptoms during the pollen season Clinical relevant disease or abnormality (past or present) other than allergic rhinitis Symptomatic perennial allergic or nonallergic rhinitis A history of asthma</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>patients</keyword>
	<keyword>allergic rhinitis</keyword>
	<keyword>tolerability</keyword>
	<keyword>safety</keyword>
	<keyword>nasal symptoms</keyword>
</DOC>